Advertisement

Topics

Vorinostat renders dormant HIV infection vulnerable to clearance

20:00 EDT 31 Jul 2017 | AAAS

(University of North Carolina Health Care) For the first time researchers at the University of North Carolina at Chapel Hill have developed an assay that can measure antigen production and clearance caused by a latency-reversing agent.

Original Article: Vorinostat renders dormant HIV infection vulnerable to clearance

NEXT ARTICLE

More From BioPortfolio on "Vorinostat renders dormant HIV infection vulnerable to clearance"

Quick Search
Advertisement
 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...